Johnson & Johnson Will Split Its Company in Two, Segment Liabilities - NewsBreak

As a $465 million Johnson & Johnson opioid lawsuit gets overturned in the Supreme Court, the drugmaker made a decision that will segment its liabilities. Johnson & Johnson will split its company in two, with one half dedicated to its pharmaceutical drugs. Article continues below advertisement. The company says...